Table 6

Antimicrobial activity, bacterial sensitivity, intermediate sensitivity and resistance to antibiotics commonly used against coagulase-negative Staphylococcus spp, Staphylococcus epidermidis and Enterococcus faecalis

Antimicrobial drugCoagulase-negative Staphylococcus spp
(26 isolates)
S epidermidis
(16 isolates)
E faecalis
(15 isolates)
MIC50MIC90S%I%R%MIC50MIC90S%I%R%MIC50MIC90S%I%R%
Fosfomycin tromethamine*0.253296.20.03.80.250.5100.00.00.03232100.00.00.0
Levofloxacin0.512850.00.050.0412843.80.056.283240.00.060.0
Moxifloxacin0.1251650.023.126.911643.831.225.018
Cefdinir0.5>25661.511.626.90.5>25656.312.531.21>256
Cefixime16>25616>2568>256
Cefaclor46469.219.311.546468.818.712.564>256
Cefprozil13288.50.011.513287.50.012.5864
Cefuroxime112888.50.011.5112887.50.012.58>256
Amoxicillin/clavulanic acid0.51688.511.50.251687.512.50.52
Cefotaxime21688.57.73.821687.512.50.02>256
Azithromycin64>25615.40.084.6>256>25618.80.081.2>256>256
Nitrofurantoin1632100.00.00.01632100.00.00.03232100.00.00.0
Oxacillin0.512838.561.50.512837.562.5
  • *Determination of the breakpoint of fosfomycin tromethamine to Enterobacteriaceae (sensitivity rate ≤64 mg/L; resistance rate ≥256 mg/L).

  • I, intermediate; MIC, minimal inhibitory concentration; R, resistant; S, susceptible.